Go to top
Commission publishes amended RTS and ITS under Article 9 of EMIR
Archive
12 Feb
2014

Trade data: seeing through the smoothie

JWG analysis. When G20 leaders met in Pittsburgh back in September 2009, there was clear consensus on the direction that the financial industry needed to take in the aftermath of the global financial crisis.  Transparency was a key theme. The view was that, by mandating industry-wide reporting obligations for OTC derivatives, regulators would be armed Read More

06 Feb
2014

The OTC mirage: As deadlines near, global trade reporting follies emerge

  • 6th February 2014
  • RegTechFS

JWG analysis. With the 12 February EMIR trade reporting deadline just around the corner, the atmosphere in the derivatives industry suggests just as much turmoil as ever. Issues surrounding LEI registration, UTI reconciliation and trade repository affiliations persist as the rush to comply with mandatory reporting rules begins.  The industry is still grappling with issues that Read More

29 Nov
2013

UPIs, UTIs and LEIs: Key issues and methods

  • 29th November 2013
  • RegTechFS

Following the success of Tony Russell’s UTI article, it seems apparent that implementing new identifiers will be a major area of difficulty prior to the start of OTC/ETD trade reporting in Februrary 2014.  The presentation below sets out the details of the proposals for the UPI and UTI, identifies some of the major issues and Read More

15 Nov
2013

Please bank responsibly: Three areas where the buy-side are being forced to take more responsibility in 2014

  • 15th November 2013
  • RegTechFS

2013 has been a real wake-up call for the buy-side.  New requirements from regulations like EMIR, AIFMD and Dodd-Frank have meant that funds, asset managers and even corporates are suddenly in regulators’ sights, some for the first time.  In the past, the reaction to such changes has frequently been to delegate new compliance responsibilities to Read More